NL-OMON21840尚未招募不适用
Intergroup trial for children or adolescents with B-Cell NHL or B-AL: Evaluation of Rituximab efficacy and safety in high risk patients.
Institut Gustave Roussy114, rue Edouard Vaillant94 805 - Villejuif France0 个研究点目标入组 640 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 640
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Children and adolescents aged until 18 years with untreated advanced stage B-cell NHL or B-AL.
排除标准
- •HISTOLOGY AND STAGING DISEASE:
- •1. Follicular lymphoma, MALT and nodular marginal zone are not included into this therapeutic study;
研究者
相似试验
已完成
3 期
A 12-Week Study To Assess The Safety Of Fluticasone Propionate/Salmeterol 100/50 Hydrofluoroalkane (HFA) Versus Fluticasone Propionate 100 HFA In Children With AsthmaAsthmaNCT00441441GlaxoSmithKline351
撤回
2 期
Treatment of Bardet-Biedl-Syndrome With Metformin for Evaluation of a Possible Visual ImprovementBardet-Biedl SyndromeVisual ImpairmentNCT03490019University Hospital Tuebingen
已完成
2 期
A Multi-Center Phase II Study in Children and Adolescence with T-AJPRN-jRCTs041180145Watanebe Arata364
已完成
2 期
Intergroup Trial for Children or Adolescents With Primary Mediastinal Large B-Cell Lymphoma: DA-EPOCH-Rituximab EvaluationPrimary Mediastinal Large B Cell LymphomaNCT01516567Gustave Roussy, Cancer Campus, Grand Paris47
招募中
1 期
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma.Hepatoblastoma and liver cancer (hepatocarcinoma)EUCTR2023-000036-30-PLMedical University of Gdansk60